|
251917
|
6505-01-390-3454
|
A Citric Acid Sodium Bicarbonate |
Picker Intl Inc
|
|
Quote
|
|
SPARKLES
|
6505-01-390-3454
|
A Citric Acid Sodium Bicarbonate |
Lafayette Pharmacal Inc
|
|
Quote
|
|
149501
|
6505-01-390-3454
|
A Citric Acid Sodium Bicarbonate |
Lafayette Pharmacal Inc
|
|
Quote
|
|
2B0843
|
6505-01-390-3712
|
Dopamine Hydrochloride And Dextr |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1007-03
|
6505-01-390-3712
|
Dopamine Hydrochloride And Dextr |
Baxter Healthcare Corp
|
|
Quote
|
|
IOPIDINE
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Alcon Laboratories Inc
|
|
Quote
|
|
94-4-22-42
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Defense Logistics Agency
|
|
Quote
|
|
0665-05
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC00065-0665-05
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Alcon Laboratories Inc
|
|
Quote
|
|
IOPIDINE
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0665-05
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
0665-05
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC17478-0716-10
|
6505-01-390-3749
|
Apraclonidine Hydrochloride Opht |
Akorn, Inc.
|
|
Quote
|
|
NDC00603-6135-21
|
6505-01-390-4853
|
Torsemide Tablets |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00037-5010-01
|
6505-01-390-4853
|
Torsemide Tablets |
Meda Pharmaceuticals, Inc
|
|
Quote
|
|
ENTROCEL
|
6505-01-390-5977
|
Us Methylcellulose Oral Solution |
Lafayette Pharmaceuticals Inc
|
|
Quote
|
|
153318
|
6505-01-390-5977
|
Us Methylcellulose Oral Solution |
Lafayette Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID
|
6505-01-390-6674
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-390-6674
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00048-1080-05
|
6505-01-390-6674
|
Usp Levothyroxine Sodium Tablets |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00048-1080-05
|
6505-01-390-6674
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID
|
6505-01-390-6689
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-390-6689
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00048-1080-03
|
6505-01-390-6689
|
Usp Levothyroxine Sodium Tablets |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00048-1080-03
|
6505-01-390-6689
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID
|
6505-01-390-6700
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-390-6700
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00048-1060-03
|
6505-01-390-6700
|
Usp Levothyroxine Sodium Tablets |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00048-1060-03
|
6505-01-390-6700
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID
|
6505-01-390-7825
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-390-7825
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00048-1130-13
|
6505-01-390-7825
|
Usp Levothyroxine Sodium Tablets |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00048-1130-13
|
6505-01-390-7825
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID
|
6505-01-390-7831
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-390-7831
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00048-1050-13
|
6505-01-390-7831
|
Usp Levothyroxine Sodium Tablets |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00048-1050-13
|
6505-01-390-7831
|
Usp Levothyroxine Sodium Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
4902-33
|
6505-01-390-8309
|
Usp Dextrose Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4902-33
|
6505-01-390-8309
|
Usp Dextrose Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
6637-33
|
6505-01-390-8314
|
Usp Sodium Bicarbonate Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-6637-33
|
6505-01-390-8314
|
Usp Sodium Bicarbonate Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC61570-0024-01
|
6505-01-390-8316
|
Usp Chlorthalidone Tablets |
Monarch Pharmaceuticals Inc
|
|
Quote
|
|
4911-33
|
6505-01-390-8328
|
Usp Atropine Sulfate Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4911-33
|
6505-01-390-8328
|
Usp Atropine Sulfate Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
4921-33
|
6505-01-390-8337
|
Usp Epinephrine Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4921-33
|
6505-01-390-8337
|
Usp Epinephrine Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
4928-33
|
6505-01-390-8416
|
Usp Calcium Chloride Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4928-33
|
6505-01-390-8416
|
Usp Calcium Chloride Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
GLUCOTROL XL
|
6505-01-391-1079
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-1550-66
|
6505-01-391-1079
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00591-0844-01
|
6505-01-391-1079
|
Usp Glipizide Tablets |
Actavis Pharma, Inc.
|
|
Quote
|
|
GLUCOTROL XL
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-1560-66
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC59762-0542-01
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Greenstone Ltd
|
|
Quote
|
|
GLIPIZIDE ER
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Greenstone Ltd
|
|
Quote
|
|
ZOSYN
|
6505-01-391-3788
|
Piperacillin Sodium And Tazobact |
American Cyanamid Co
|
|
Quote
|
|
NDC00206-8620-11
|
6505-01-391-3788
|
Piperacillin Sodium And Tazobact |
American Cyanamid Co
|
|
Quote
|
|
9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
NDC00074-9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
NDC00074-9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
NDC52244-0404-10
|
6505-01-391-4612
|
Acrivastine And Pseudoephedrine |
Ucb Pharma, Inc.
|
|
Quote
|
|
NDC52244-0404-10
|
6505-01-391-4612
|
Acrivastine And Pseudoephedrine |
Ucb Pharma, Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00378-6989-62
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC49502-0685-26
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Mylan Specialty L.p.
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
CATAFLAM
|
6505-01-391-6112
|
Diclofenac Potassium Tablets |
Ciba
|
|
Quote
|
|
NDC00028-0151-01
|
6505-01-391-6112
|
Diclofenac Potassium Tablets |
Ciba
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC000338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corporation
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corporation
|
|
Quote
|
